Cevimeline Hydrochloride Capsule
Product Images NDC 0054-0893

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 0054-0893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cevimeline-caps-label (Bottle Label 30mg)

Label for cevimeline hydrochloride capsules, 30 mg strength, in a 100-capsule package. The label shows storage instructions (20° to 25°C), dispensing guidelines, and manufacturer information (Hikma Pharmaceuticals LLC, Jordan) with distribution by Hikma Pharmaceuticals USA Inc. The label includes an NDC number 0054-0893-25 and a barcode, with the Hikma logo in red.*

FDA Label Image

Chemical Stucture (Chem Structure)

Chemical structure of cevimeline hydrochloride including its enantiomer, with notation for hydrochloride (HCl) and half molecule of water (1/2 H2O) hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.